SOPHiA GENETICS to release Q2 2025 financial results on Aug 5.
PorAinvest
martes, 22 de julio de 2025, 8:05 am ET1 min de lectura
SOPH--
SOPHiA GENETICS specializes in using AI to deliver world-class care to patients with cancer and rare disorders across the globe. The company's SOPHiA DDM™ Platform analyzes complex multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions [1].
The company's mission is to expand access to data-driven medicine and has been recognized for its innovative approach. It was named one of the World's most innovative companies and the World's smartest companies, among other accolades [2].
In the first quarter of 2025, SOPHiA GENETICS reported revenue of $17.8 million, up 13% year-over-year (YoY) (15% constant currency). The company achieved a record adjusted gross margin of 75.7%, improving from 70.5% the previous year. While IFRS net loss increased 27% to $17.4 million, adjusted EBITDA loss improved 24% to $9.8 million. Key operational highlights included performing 93,000 analyses (+11% YoY), reaching 490 core genomics customers, and expanding its operational footprint [3].
Investors and stakeholders are encouraged to tune in to the conference call to gain insights into SOPHiA GENETICS' performance and future prospects. The webcast will provide an opportunity to hear directly from the company's leadership and understand the strategic direction of the business.
References:
[1] https://www.marketscreener.com/news/sophia-genetics-to-announce-financial-results-for-second-quarter-2025-on-august-5-2025-ce7c5cdcd081ff23
[2] https://builtin.com/job/senior-software-engineer/6673348
[3] https://www.stocktitan.net/news/SOPH/
• SOPHiA GENETICS to release Q2 2025 financial results on Aug 5, 2025. • Conference call to discuss results and business outlook at 8:00 a.m. EDT. • Webcast live on SOPHiA GENETICS Investor Relations Website. • Company is a software provider in data-driven medicine for cancer and rare disorders.
SOPHiA GENETICS (Nasdaq: SOPH), a leading software provider in data-driven medicine, has announced that it will release its financial results for the second quarter of 2025 on August 5, 2025. The company will host a conference call to discuss the results and business outlook at 8:00 a.m. EDT (2:00 p.m. CET). The call will be webcast live on the SOPHiA GENETICS Investor Relations Website, with a replay available after the completion of the call [1].SOPHiA GENETICS specializes in using AI to deliver world-class care to patients with cancer and rare disorders across the globe. The company's SOPHiA DDM™ Platform analyzes complex multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions [1].
The company's mission is to expand access to data-driven medicine and has been recognized for its innovative approach. It was named one of the World's most innovative companies and the World's smartest companies, among other accolades [2].
In the first quarter of 2025, SOPHiA GENETICS reported revenue of $17.8 million, up 13% year-over-year (YoY) (15% constant currency). The company achieved a record adjusted gross margin of 75.7%, improving from 70.5% the previous year. While IFRS net loss increased 27% to $17.4 million, adjusted EBITDA loss improved 24% to $9.8 million. Key operational highlights included performing 93,000 analyses (+11% YoY), reaching 490 core genomics customers, and expanding its operational footprint [3].
Investors and stakeholders are encouraged to tune in to the conference call to gain insights into SOPHiA GENETICS' performance and future prospects. The webcast will provide an opportunity to hear directly from the company's leadership and understand the strategic direction of the business.
References:
[1] https://www.marketscreener.com/news/sophia-genetics-to-announce-financial-results-for-second-quarter-2025-on-august-5-2025-ce7c5cdcd081ff23
[2] https://builtin.com/job/senior-software-engineer/6673348
[3] https://www.stocktitan.net/news/SOPH/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios